Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.130
+0.130 (4.33%)
At close: Jan 9, 2026, 4:00 PM EST
3.100
-0.030 (-0.96%)
After-hours: Jan 9, 2026, 6:17 PM EST
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $5.52 million as of January 9, 2026. Its market cap has decreased by -51.05% in one year.
Market Cap
5.52M
Enterprise Value
-300.79K
1-Year Change
-51.05%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $5.52M, a decrease of -88.50%. That is a compound annual growth rate of -38.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 5.25M | 3.09% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |